Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Humacyte Inc
(NQ:
HUMA
)
5.390
+0.340 (+6.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Humacyte Inc
< Previous
1
2
3
4
5
Next >
Humacyte Announces Fourth Quarter and Year End 2022 Financial Results and Business Update
March 24, 2023
From
Humacyte, Inc
Via
GlobeNewswire
Earnings Preview For Humacyte
March 23, 2023
Via
Benzinga
Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023
March 21, 2023
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte to Present at Upcoming Investor Conferences in March
February 27, 2023
From
Humacyte, Inc
Via
GlobeNewswire
5 Value Stocks In The Healthcare Sector
February 13, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 26, 2022
Via
Benzinga
Humacyte's Return on Invested Capital Insights
December 19, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 13, 2023
Via
Benzinga
Humacyte Publication in the Journal of Vascular Surgery – Vascular Science Reports the Human Acellular Vessel™ (HAV™) Remains Durable at Six Years in Patients with Peripheral Artery Disease
January 24, 2023
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte Hosting Key Opinion Leader Webinar on Vascular Trauma: Ukrainian Surgeons Discuss Use of Human Acellular Vessels™ (HAV™) in Wartime
December 13, 2022
Thursday, December 15, 2022 @ 8:00 AM ET
From
Humacyte, Inc
Via
GlobeNewswire
Sidoti's December Small-Cap Virtual Conference
December 06, 2022
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Humacyte Human Acellular Vessel™ (HAV™) Ukraine Humanitarian Results to be Presented at Multiple Vascular Conferences in December 2022
December 01, 2022
Ukrainian surgeon collaborators will present at the VI Congress of Vascular Surgeons, Phlebologists, and Angiologists of Ukraine and the 11th Munich Vascular Conference
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte to Present at the 34th Annual Piper Sandler Healthcare Conference
November 23, 2022
From
Humacyte, Inc
Via
GlobeNewswire
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
November 21, 2022
U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 15, 2022
On Tuesday, 34 companies set new 52-week lows.
Via
Benzinga
Humacyte Third Quarter 2022 Financial Results and Business Update
November 10, 2022
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte Presents Six-Month Human Acellular Vessel™ (HAV™) Coronary Artery Bypass Graft (CABG) Data at the American Heart Association Scientific Sessions 2022 Meeting
November 07, 2022
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 10, 2022
November 03, 2022
From
Humacyte, Inc
Via
GlobeNewswire
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
September 12, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Humacyte Earnings Perspective: Return On Invested Capital
September 09, 2022
According to Benzinga Pro, during Q2, Humacyte (NASDAQ:HUMA) earned $36.87 million, a 285.9% increase from the preceding quarter. Humacyte also posted a total of $1.30 million in sales, a 458.37%...
Via
Benzinga
Earnings Scheduled For August 12, 2022
August 12, 2022
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 06, 2022
Via
Benzinga
41 Stocks Moving In Monday's Mid-Day Session
May 16, 2022
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.
Via
Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
August 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
Via
Benzinga
95 Biggest Movers From Yesterday
June 07, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...
Via
Benzinga
52 Stocks Moving In Monday's Mid-Day Session
June 06, 2022
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Via
Benzinga
Earnings Scheduled For May 13, 2022
May 13, 2022
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million.
Via
Benzinga
73 Biggest Movers From Yesterday
May 17, 2022
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.